Jennifer I. Lim, MD, FASRS, FARVO, and Rahul N. Khurana, MD, FASRS, highlight a few of the barriers facing marginalized populations when accessing care and provide strategies on leveling the playing field.
Strategies for Progress: Reducing Disparities in Retinal Treatment - Closing Treatment Gaps
Media formats available:
Details
Presenters
Target Audience
This certified continuing medical education activity is designed for retina specialists involved in the care of patients with diabetic retinal disease and age-related macular degeneration.
Grantor Statement
This activity is supported by an unrestricted educational grant from Regeneron.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Examine the influence of social determinants of health on access to retinal disease care
- Develop strategies to reduce disparities in the management of retinal diseases by improving access and adherence to treatments in historically marginalized populations
- Compare the efficacy and outcomes of treatment across different racial and socioeconomic populations with diabetic macular edema
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Faculty
Jennifer, I. Lim, MD, FASRS, FARVOProgram ChairMarion H. Schenk Chair in OphthalmologyVice-Chair for Diversity, Equity & InclusionDirector of the Retina ServiceUIC Distinguished Professor of OphthalmologyUniversity of Illinois at ChicagoChicago, IL
Rahul N. Khurana, MD, FASRS
Northern California Retina Vitreous Associates
Clinical Associate Professor, Ophthalmology
University of California
San Francisco Medical Center
San Francisco, CADisclosure of Relevant Financial Relationships
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.Jennifer, I. Lim, MD,FASRS, FARVO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie/Allergan, Astellas/Iveric Bio, Aura Biosciences, Cognition, EyePoint Pharmaceuticals, Eyenuk, Genentech, Luxa, Opthea, Regeneron, Unity, and Viridian. Advisory Board: Alcon, Alimera, Apellis Pharmaceuticals, Bausch + Lomb, and Ocular Therapeutix. Grant/Research Support: Aldeyra, Genentech, Graybug, Janssen/Johnson & Johnson, Kyoto Drug/Discovery, NGM, Ocular Therapeutix, Regeneron, Regenxbio, Spring Vision, and Stealth.
Rahul N. Khurana, MD, FASRS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Clearside Biomedical, Genentech/Roche, and Regeneron. Grant/Research Support: Annexion, Apellis Pharmaceuticals, Clearside Biomedical, Opthea, Regenxbio, and Roche.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Katherine E. Talcott, MD
Ferhina S Ali, MD, MPH, FASRS
Durga Borkar, MD, MMCi
Theodore Leng, MD, MS
Danny Mammo, MD
Yasha S. Modi, MD, MHS
John Kitchens, MD
Sara LeMay, OD
Dean Eliott, MD
Charles C. Wykoff, MD, PhD, FACS
Thomas Albini, MD
Roger A. Goldberg, MD, MBA
Dean Eliott, MD
Charles C. Wykoff, MD, PhD, FACS
